5 terminated. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Terminated 5 |
Follow Renal Impairment: new trials by email Literature Review of Renal Impairment trials Research Report on Renal Impairment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment Insulin glargine 300 U/mL, Insulin degludec 100 U/mL - Type 2 Diabetes Mellitus, Renal Impairment | Phase 4 | Terminated | Sanofi | 62 | 2022-12-05 | 2025-09-08 |
| Neurotoxic Adverse Effects of Morphine and Oxycodone for Pain in Terminal Patients With Diminished Renal Function Oxycodone, Morphine - Pain, Terminal Illness | Phase 4 | Terminated | Maastricht University Medical Center | 8 | 2018-06-04 | 2019-03-18 |
| Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment Vancomycin, Daptomycin, Semi-Synthetic Penicillin - Complicated Skin and Skin Structure Infections, S. Aureus Bacteremia | Phase 4 | Terminated | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 92 | 2010-04-19 | 2018-09-05 |
| A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment Gabapentin - Renal Impairment | Phase 4 | Terminated | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 | 2010-03-01 | 2021-02-03 |
| Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography Ioversol 320 mgI/mL, Iodixanol 320 mgI/mL - Renal Impairment | Phase 4 | Terminated | Guerbet | 6 | 2009-01-01 | 2019-03-06 |
Renal Insufficiency (5) · Diabetes Mellitus, Type 2 (1) · Pain (1)
Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Kidney Diseases (5) · Male Urogenital Diseases (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Neurologic Manifestations (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Cloxacillin (1) · Daptomycin (1) · Gabapentin (1) · Insulin Glargine (1) · Morphine (1) · Nafcillin (1) · Oxacillin (1) · Oxycodone (1) · Vancomycin (1) · insulin degludec (1) · iodixanol (1) · ioversol (1)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1) · Guerbet (1) · Maastricht University Medical Center (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Sanofi (1)
United States (3) · Czechia (1) · Hungary (1) · Japan (1) · Netherlands (1) · Poland (1) · Serbia (1)
Eddie Darton, MD (1) · Ellie Hershberger, Pharm.D. (1) · Jos MG Schols, MD PhD (1) · Mark JM Martens, MD (1) · Sander MJ van Kuijk, PhD (1)